JHS Svendgaard Laboratories (BOM:532771) Cash-to-Debt : 2.23 (As of Mar. 2024)

View and export this data going back to 2006. Start your Free Trial

What is JHS Svendgaard Laboratories Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. JHS Svendgaard Laboratories's cash to debt ratio for the quarter that ended in Mar. 2024 was 2.23.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, JHS Svendgaard Laboratories could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for JHS Svendgaard Laboratories's Cash-to-Debt or its related term are showing as below:

BOM:532771' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.05 Med: 1.76 Max: 9.77
Current: 2.23

During the past 13 years, JHS Svendgaard Laboratories's highest Cash to Debt Ratio was 9.77. The lowest was 0.05. And the median was 1.76.

BOM:532771's Cash-to-Debt is ranked better than
72% of 1843 companies
in the Consumer Packaged Goods industry
Industry Median: 0.52 vs BOM:532771: 2.23

JHS Svendgaard Laboratories Cash-to-Debt Historical Data

The historical data trend for JHS Svendgaard Laboratories's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

JHS Svendgaard Laboratories Cash-to-Debt Chart

JHS Svendgaard Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Cash-to-Debt

Get a 7-Day Free Trial

0.81

3.29

1.30

2.44

2.23

JHS Svendgaard Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial															2.44	N/A	14.67	N/A	2.23

Competitive Comparison of JHS Svendgaard Laboratories's Cash-to-Debt

For the Household & Personal Products subindustry, JHS Svendgaard Laboratories's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JHS Svendgaard Laboratories's Cash-to-Debt Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, JHS Svendgaard Laboratories's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where JHS Svendgaard Laboratories's Cash-to-Debt falls into.

JHS Svendgaard Laboratories Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

JHS Svendgaard Laboratories's Cash to Debt Ratio for the fiscal year that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	114.296	/	(39.613	+	11.674)
	=	2.23

JHS Svendgaard Laboratories's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	114.296	/	(39.613	+	11.674)
	=	2.23

JHS Svendgaard Laboratories (BOM:532771) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

JHS Svendgaard Laboratories Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of JHS Svendgaard Laboratories's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

JHS Svendgaard Laboratories (BOM:532771) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JHS Svendgaard Laboratories Ltd (BOM:532771) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

JHS:India

Address

Mathura Road, B-1/E-23, Mohan Co-operative Industrial Area, New Delhi, IND, 110044

Website

https://www.svendgaard.com

JHS Svendgaard Laboratories Ltd is a manufacturer of dental and oral care products. Its business segments include Manufacturing Business; Other than Manufacturing Business and Retail Business. Its product portfolio includes a toothbrush, toothpaste, mouthwash, laundry detergent, hand sanitizer, and room fresheners. It sells products under its own brand name and private labels including Dr. Gold, P&G, Amway, Future Group, Dabur, Elder Pharma, J. L. Morison's among others, and in the international market are - Dr. Fresh, Boots, Peanuts, and Lavoris. It generates the majority of the revenue from the Manufacturing Business segment.

JHS Svendgaard Laboratories (BOM:532771) Headlines

No Headlines